These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20685601)

  • 1. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.
    Pearton M; Kang SM; Song JM; Kim YC; Quan FS; Anstey A; Ivory M; Prausnitz MR; Compans RW; Birchall JC
    Vaccine; 2010 Aug; 28(37):6104-13. PubMed ID: 20685601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
    Song JM; Kim YC; Lipatov AS; Pearton M; Davis CT; Yoo DG; Park KM; Chen LM; Quan FS; Birchall JC; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Clin Vaccine Immunol; 2010 Sep; 17(9):1381-9. PubMed ID: 20631330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.
    Pearton M; Pirri D; Kang SM; Compans RW; Birchall JC
    Adv Healthc Mater; 2013 Oct; 2(10):1401-10. PubMed ID: 23564440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
    Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
    Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
    Hendin HE; Pillet S; Lara AN; Wu CY; Charland N; Landry N; Ward BJ
    Vaccine; 2017 May; 35(19):2592-2599. PubMed ID: 28389100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.
    Won SY; Hunt K; Guak H; Hasaj B; Charland N; Landry N; Ward BJ; Krawczyk CM
    Vaccine; 2018 Dec; 36(52):8028-8038. PubMed ID: 30448064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
    Kim YC; Song JM; Lipatov AS; Choi SO; Lee JW; Donis RO; Compans RW; Kang SM; Prausnitz MR
    Eur J Pharm Biopharm; 2012 Jun; 81(2):239-47. PubMed ID: 22504442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
    Quan FS; Kim YC; Vunnava A; Yoo DG; Song JM; Prausnitz MR; Compans RW; Kang SM
    J Virol; 2010 Aug; 84(15):7760-9. PubMed ID: 20484519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
    Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
    Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
    Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
    J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response.
    Hodgins B; Yam KK; Winter K; Pillet S; Landry N; Ward BJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.
    Pearton M; Kang SM; Song JM; Anstey AV; Ivory M; Compans RW; Birchall JC
    PLoS One; 2010 Aug; 5(8):e12410. PubMed ID: 20811642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages.
    Makarkov AI; Chierzi S; Pillet S; Murai KK; Landry N; Ward BJ
    Vaccine; 2017 Aug; 35(35 Pt B):4629-4636. PubMed ID: 28712489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development.
    Hong JY; Chen TH; Chen YJ; Liu CC; Jan JT; Wu SC
    Antiviral Res; 2019 Apr; 164():12-22. PubMed ID: 30738089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
    Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
    J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
    Lindsay BJ; Bonar MM; Costas-Cancelas IN; Hunt K; Makarkov AI; Chierzi S; Krawczyk CM; Landry N; Ward BJ; Rouiller I
    Vaccine; 2018 Apr; 36(16):2147-2154. PubMed ID: 29550194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.